Literature DB >> 30702236

Venom Immunotherapy: a 20-year experience with an ultra-rush protocol (210-min).

J Cosme1, A Spínola-Santos1, M C Pereira-Santos2,3, M Pereira-Barbosa1,3.   

Abstract

SUMMARY: Background. Ultra-rush (UR) are induction protocols used in venom immunotherapy (VIT).
Objectives: To evaluate the adverse reactions during a 210-minutes UR and determine possible risk factors.
Methods: Retrospective study of 129 patients submitted to UR with VIT in the last 20 years.
Results: In 114 (88.4%) patients the 101.1 μg maintenance dose was reached in 210 minutes. Systemic reactions (SR) occurred in 22% of patients (71% mild). There were no severe SR, late reactions or fatalities. Adrenaline was administered in 10% of all UR. The SR were more frequent with honey bee VIT and had greater severity in the patients with a previous severe systemic sting reaction. No significant difference in the risk of SR was found with other demographic, clinical or laboratory factors. There were 5% of large local reactions (LLR), these being more frequent in females.
Conclusion: Most SR during UR were mild with no need for adrenaline treatment. The honey bee venom and the severity of the anaphylaxis during the field sting were the only SR´s risk factors for systemic adverse reactions during the UR.

Entities:  

Keywords:  Adverse reactions; honey-bee; paper wasp; ultra-rush; wasp

Year:  2019        PMID: 30702236     DOI: 10.23822/EurAnnACI.1764-1489.85

Source DB:  PubMed          Journal:  Eur Ann Allergy Clin Immunol        ISSN: 1764-1489


  3 in total

Review 1.  Clinical Utility of Rush Venom Immunotherapy: Current Status.

Authors:  Vianney Gruzelle; Claire Mailhol; David W Waters; Laurent Guilleminault
Journal:  J Asthma Allergy       Date:  2020-01-07

2.  Safety and tolerability of venom immunotherapy: Evaluation of 581 rush- and ultra-rush induction protocols (safety of rush and ultra-rush venom immunotherapy).

Authors:  Richard Stock; Tatjana Fischer; Katharina Aẞmus; Nadja Zoeller; Hanns Ackermann; Roland Kaufmann; Markus Meissner; Eva Valesky
Journal:  World Allergy Organ J       Date:  2020-12-15       Impact factor: 4.084

3.  Adverse reactions in venom immunotherapy protocols: conventional versus ultra-rush.

Authors:  Ali Selcuk; Abdullah Baysan; Sait Yesillik; Fevzi Demirel; Ozgur Kartal; Mustafa Gulec; Ugur Musabak; Osman Sener
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.